使用诱导多能干细胞进行体外游戏生殖的建模:一篇综述
Maria Victoria Romualdez-Tan1,2
1Present Address: Repro Optima Center for Reproductive Health, Inc., Ground Floor JRDC Bldg. Osmena Blvd. Capitol Site, Cebu City, 6000, Philippines. marivic.tan@repro-optima.com.
Cell regeneration (London, England)
|October 16, 2023
概括
诱导多能干细胞 (iPSCs) 在体外生育生成 (IVG) 研究中取得了重大进展,为不孕症治疗提供了新的途径. 本综述涵盖了iPSC衍生,IVG方法和未来的应用,同时注意到道德方面的考虑.
科学领域:
- 生殖生物学 生殖生物学
- 干细胞研究的研究.
- 发育生物学是发展生物学.
背景情况:
- 试管婴儿发育 (IVG) 研究旨在复制生殖细胞发育的医学应用,特别是不孕症治疗.
- 早期的IVG方法依赖于胚胎干细胞 (ESC),但由于细胞来源稀缺和道德问题而面临限制.
- 诱导多能干细胞 (iPSC) 已经成为一个有希望的替代品,克服了与ESC相关的局限性.
研究的目的:
- 审查使用诱导多能干细胞 (iPSCs) 进行体外生殖 (IVG) 的最新进展.
- 讨论获得iPSC的技术,强调无转基因iPSC对于提高IVG疗效的重要性.
- 探索基于iPSC的IVG的当前和潜在的未来临床应用.
主要方法:
- 现有关于体外生育细胞 (IVG) 和诱导多能干细胞 (iPSCs) 的文献的综述.
- 讨论使用ESC的基础IVG研究中的关键概念及其对iPSC的适用性.
- 分析最近关于iPSC衍生性游戏生成阶段和临床应用的研究.
主要成果:
- 在试验室中,iPSC技术使得在复制性游戏生殖方面取得了显著进展.
- 对于有效的IVG来说,获得具有高生殖系传播能力的无转基因iPSC的方法至关重要.
- 目前正在探索基于iPSC的IVG的当前和未来的临床应用,它有可能彻底改变生殖医学.
结论:
- 虽然有效性,安全性和技术方面的挑战仍然存在,但基于iPSC的IVG对生殖医学具有巨大的前景.
- 新的IVG方法不断出现,可能导致不孕症治疗的突破.
- IVG技术的发展需要仔细考虑道德和社会影响,以确保负责任的进步.
相关概念视频
Induced Pluripotent Stem Cells
24.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.0K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


